BioCryst Pharmaceuticals Stock News & Updates
[WKN: 896047 | Symbol: BCRX]
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals: Bank of America Sees Approximately 130% Price Potential!
BioCryst Pharmaceuticals (BCRX): Profitability Outlook for 2025 Triggers a Breakout to a 52-Week High!
BioCryst Pharmaceuticals Inc. (BCRX) (i.) specializes in rare diseases. The company's main product is...
Stocks in Action USA: Worthington, BioCryst and NAPCO Securities
Canaccord Genuity upgrades Worthington (WOR) to Buy – Strong margins and solid segment development...
BioCryst Pharmaceuticals (BCRX): Investors Reward Forecast Increase With a Share Price Increase to a 52-Week High!
BioCryst Pharmaceuticals Inc. (BCRX) (i.) has smashed expert expectations with its first-quarter numbers...
BioCryst Pharmaceuticals (BCRX): Investors Reward Forecast Upgrade With Stock Surge to a 52-Week High!
BioCryst Pharmaceuticals Inc. (BCRX) (i.) crushed analysts' expectations with the numbers released for...
- ‹
- 1
- ›